hit counter
Amphastar Pharmaceuticals, Inc. (AMPH) Stock News Sentiment & Price - Sentifly
AMPH - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Amphastar Pharmaceuticals, Inc. (AMPH)

USA
Drug Manufacturers - Other
NASDAQ
AMPH Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
AMPH Latest news
Accesswire
Neutral
Amphastar Pharmaceuticals to Present at the Wells Fargo 2021 Virtual Healthcare Conference
2021-09-02 16:05

RANCHO CUCAMONGA, CA / ACCESSWIRE / September 2, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, Executive V.P. and CFO, Dan Dischner, V.P of Corporate Communications, Tony Marrs, Sr. V.P Regulatory Affairs and Clinical Operations, and Jacob Liawatidewi, Executive V.P.

Zacks Investment Research
Positive
3 Generic Drug Stocks to Watch Amid Pandemic & Pricing Pressure
2021-08-17 12:10

The impact of the coronavirus pandemic on the Zacks Medical-Generic Drugs industry is expected to recede in the second half of 2021. Moreover, stable pricing and improving demand in some countries in 2021 may bode well for RDY, BHC and AMPH.

Seeking Alpha
Neutral
Amphastar Pharmaceuticals, Inc. (AMPH) on Q2 2021 Results - Earnings Call Transcript
2021-08-09 23:52

Amphastar Pharmaceuticals, Inc. (AMPH) on Q2 2021 Results - Earnings Call Transcript

Zacks Investment Research
Neutral
Amphastar Pharmaceuticals (AMPH) Meets Q2 Earnings Estimates
2021-08-09 19:59

Amphastar (AMPH) delivered earnings and revenue surprises of 0.00% and 0.28%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Accesswire
Neutral
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2021
2021-08-09 16:05

Reports Net Revenues of $101.7 Million for the Three Months Ended June 30, 2021 RANCHO CUCAMONGA, CA / ACCESSWIRE / August 9, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months ended June 30, 2021. Second Quarter Highlights Net revenues of $101.7 million for the second quarter GAAP net income of $7.8 million, or $0.16 per share, for the second quarter Adjusted non-GAAP net income of $10.6 million, or $0.21 per share, for the second quarter Dr. Jack Zhang, Amphastar's President and Chief Executive Officer, commented: "Continued strong sales of glucagon, Primatene Mist® and our epinephrine products led to another strong quarter of growth.

Zacks Investment Research
Positive
Amphastar Pharmaceuticals (AMPH) to Report Q2 Results: Wall Street Expects Earnings Growth
2021-07-29 16:44

Amphastar (AMPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Accesswire
Neutral
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 9th, 2021
2021-07-29 16:20

RANCHO CUCAMONGA, CA / ACCESSWIRE / July 29, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2021 ended June 30, 2021, after the market closes on Monday, August 9th, 2021, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.

GlobeNewsWire
Neutral
Amphastar Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference
2021-06-15 16:05

RANCHO CUCAMONGA, Calif., June 15, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, Executive V.P. and CFO, Dan Dischner, V.P of Corporate Communications, Tony Marrs, Sr. V.P Regulatory Affairs and Clinical Operations, and Jacob Liawatidewi, Executive V.P. Corporate Administration Center and Sales & Marketing, will be presenting at the Human Health Innovation Conference on Tuesday, June 22, 2021, at 2:00 pm Eastern time.

GlobeNewsWire
Neutral
Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
2021-05-27 06:00

RANCHO CUCAMONGA, Calif., May 27, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, Executive V.P. and CFO, Dan Dischner, V.P of Corporate Communications, Tony Marrs, Sr. V.P Regulatory Affairs and Clinical Operations, and Jacob Liawatidewi, Executive V.P. Corporate Administration Center and Sales & Marketing, will participate in an Analyst-Moderated fireside chat at the Jefferies Virtual Healthcare Conference on Thursday, June 3, 2021 at 2:30 pm Eastern time.

Seeking Alpha
Neutral
Amphastar Pharmaceuticals, Inc. (AMPH) Management on Q1 2021 Results - Earnings Call Transcript
2021-05-09 04:48

Amphastar Pharmaceuticals, Inc. (AMPH) Management on Q1 2021 Results - Earnings Call Transcript

Loading more news...